InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-26 · accession 0001415889-24-009158 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-26 2024-03-26 HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $11.20 +11.6K 165.3K +8% +$130.2K
DM 2024-03-26 2024-03-26 HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $0.00 -11.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-26 M A 8,436 $12.07 164,994 D — —
2 Common Common Stock 2024-03-26 M A 2,890 $8.11 168,176 D — —
3 Common Common Stock 2024-03-26 M A 292 $16.78 165,286 D — —
4 Derivative Option to Purchase Common Stock 2024-03-26 M D 2,890 $0.00 61,715 D $8.11 · — to 2026-02-03 2,890 Common Stock (F6) This option was granted on February 3, 2016 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
5 Derivative Option to Purchase Common Stock 2024-03-26 M D 292 $0.00 0 D $16.78 · — to 2028-07-02 292 Common Stock (F5) This option was granted on July 2, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
6 Derivative Option to Purchase Common Stock 2024-03-26 M D 8,436 $0.00 0 D $12.07 · — to 2027-02-22 8,436 Common Stock (F4) This option was granted on February 22, 2017 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.